Clinical Trials Logo

Pre-Exposure Prophylaxis clinical trials

View clinical trials related to Pre-Exposure Prophylaxis.

Filter by:
  • Not yet recruiting  
  • Page 1

NCT ID: NCT06408142 Not yet recruiting - Clinical trials for Human Immunodeficiency Virus

Universal Test and Connect for HIV Service Delivery in South Africa

UTC-SA
Start date: September 1, 2024
Phase:
Study type: Observational

The goal of this study is to determine how many patients with HIV or at high risk of getting HIV attend the Emergency Department (ED) in South Africa (SA). the investigators will integrate HIV assessment in the ED and see how many people who would be a candidate for a drug that prevents HIV (PrEP). Universal test and connect (UTC) is a strategy that universally tests all patients and connects patients to long-term care, whether HIV positive or negative, including referrals for PrEP. The investigator's goal is to use UTC across two busy 24-hr EDs in Cape Town, SA.

NCT ID: NCT06046079 Not yet recruiting - HIV Clinical Trials

Predictors of Health Service Utilizations Among Key Population in Washington DC

Start date: September 15, 2023
Phase:
Study type: Observational

The primary objective of the proposed study is to investigate how PrEP use might result in an increase in the utilization of health and social services offered at a local community-based organization.Our primary hypothesis is that we will observe higher utilization of sexual health (STI screenings), psychosocial health (psychotherapy, and substance use treatment) and other social services (emergency cash assistance, food pantry, transportation assistance, clothing,and housing resources) among PrEP users (LAI-PrEP or daily oral) compared to participants who are PrEP naïve over the 12-month follow-up period.

NCT ID: NCT05753683 Not yet recruiting - HIV Clinical Trials

Gathering Online for Dialogue and Discussion to Enhance Social Support

GODDESS
Start date: August 2024
Phase: N/A
Study type: Interventional

The goal of this trial is to test a modified mobile health intervention (with a group component) relative to a mobile health intervention in a two-arm randomized trial with 500 young African American women who are human immunodeficiency virus (HIV)-negative and who misuse alcohol. The expected outcomes are to: (1) determine the efficacy of the virtual group component in reducing alcohol use and sexual risk and increasing pre-exposure prophylaxis (PrEP) utilization; and (2) understand selected outcomes for implementation. Participants will be randomized to receive either the mHealth app or the mHealth app plus the group component, and followed up at 3-, 6-, 9-, and 12-months post-enrollment.